Results-Based Financing Impact Evaluation Health Facility 2017, Endline Survey
Burkina Faso, 2017
Get Microdata
Reference ID
BFA_2017_HRBFIE-FEL_v01_M
Producer(s)
Manuela de Allegri, Herve Hien, Paul Jacob Robyn
Collection(s)
Metadata
Created on
Aug 27, 2019
Last modified
Oct 01, 2019
Page views
71981
Downloads
1638
F6_219_M (f6_219_6)
Data file: f6_jul19
Overview
Valid:
31
Invalid:
0
Type:
Discrete
Start:
495
End:
524
Width:
30
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 00 | 13 |
41.9%
|
|
| 2 | 2 |
6.5%
|
|
| Artesunate inj | 1 |
3.2%
|
|
| Diazepam | 1 |
3.2%
|
|
| Gentamycine collyre | 1 |
3.2%
|
|
| OPPI | 1 |
3.2%
|
|
| SGI5%250 | 1 |
3.2%
|
|
| SRO sachet | 1 |
3.2%
|
|
| amoxi,para | 1 |
3.2%
|
|
| ceftri | 1 |
3.2%
|
|
| chlorphéniramide comp | 1 |
3.2%
|
|
| lumartem,para,albendazole,amox | 1 |
3.2%
|
|
| novalgin | 1 |
3.2%
|
|
| para | 1 |
3.2%
|
|
| para,chlor | 1 |
3.2%
|
|
| paracetamole | 1 |
3.2%
|
|
| perfuseur | 1 |
3.2%
|
|
| ranferon | 1 |
3.2%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.